FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2089660436> ?p ?o ?g. }

• W2089660436 endingPage "179" @default.
• W2089660436 startingPage "172" @default.
• W2089660436 abstract "Neutropenia and its complications, including febrile neutropenia (FN), are a common side effect of cancer chemotherapy. Results of clinical trials showed that prophylactic use of granulocyte colony-stimulating factors (G-CSF) is effective in preventing FN. In this study, the cost effectiveness (measured as cost per quality-adjusted time [days]) of three treatment alternatives were evaluated: no G-CSF, filgrastim administered daily for 7-12 days after chemotherapy, and a pegylated form of G-CSF pegfilgrastim, administered once per cycle.A cost-utility model based on standard clinical practice of treating FN with immediate hospitalization or with ambulatory treatment, from a societal perspective was developed. Direct medical cost estimates for hospitalization were derived from claims data reported by 115 US academic medical centers. Indirect medical costs, productivity costs, probabilities, and utilities are based on published literature. Results were subjected to sensitivity analyses and 95% confidence intervals are based on a Monte Carlo simulation.Mean estimated costs/day of hospitalization were $1984 (SD $1040, N = 24,687) for surviving patients and $3139 (SD $2014, N = 1437) for dying patients. Under baseline conditions, pegfilgrastim dominated both filgrastim and no G-CSF, with expected costs and effectiveness of $4203 and 12.361 quality adjusted life-days (QALDs) for no G-CSF, $3058 and 12.967 QALDs for pegfilgrastim, and $5264 and 12.698 QALDs for filgrastim.This cost-utility analysis provides strong evidence that pegfilgrastim is not only cost-effective but also cost-saving in most common clinical and economic settings. There appear to be both clinical and economic benefits from prophylactic administration of pegfilgrastim." @default.
• W2089660436 created "2016-06-24" @default.
• W2089660436 creator A5011425931 @default.
• W2089660436 creator A5044262860 @default.
• W2089660436 creator A5073060840 @default.
• W2089660436 creator A5090143035 @default.
• W2089660436 date "2008-03-01" @default.
• W2089660436 modified "2023-09-26" @default.
• W2089660436 title "Economic Analysis of Prophylactic Pegfilgrastim in Adult Cancer Patients Receiving Chemotherapy" @default.
• W2089660436 cites W1883242214 @default.
• W2089660436 cites W1966875672 @default.
• W2089660436 cites W1993941594 @default.
• W2089660436 cites W2024933507 @default.
• W2089660436 cites W2026500950 @default.
• W2089660436 cites W2036450045 @default.
• W2089660436 cites W2055543087 @default.
• W2089660436 cites W2058294694 @default.
• W2089660436 cites W2077781144 @default.
• W2089660436 cites W2083336892 @default.
• W2089660436 cites W2085608271 @default.
• W2089660436 cites W2089340094 @default.
• W2089660436 cites W2093205745 @default.
• W2089660436 cites W2100082529 @default.
• W2089660436 cites W2110946703 @default.
• W2089660436 cites W2117158766 @default.
• W2089660436 cites W2118522197 @default.
• W2089660436 cites W2122658272 @default.
• W2089660436 cites W2133120925 @default.
• W2089660436 cites W2136300726 @default.
• W2089660436 cites W2142195688 @default.
• W2089660436 cites W2152807596 @default.
• W2089660436 cites W2154011558 @default.
• W2089660436 cites W2163882002 @default.
• W2089660436 cites W2166858780 @default.
• W2089660436 cites W2169203358 @default.
• W2089660436 cites W2316501895 @default.
• W2089660436 cites W2341557816 @default.
• W2089660436 cites W4232293309 @default.
• W2089660436 cites W4238856605 @default.
• W2089660436 cites W4255760502 @default.
• W2089660436 cites W47581107 @default.
• W2089660436 doi "https://doi.org/10.1111/j.1524-4733.2007.00242.x" @default.
• W2089660436 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18380630" @default.
• W2089660436 hasPublicationYear "2008" @default.
• W2089660436 type Work @default.
• W2089660436 sameAs 2089660436 @default.
• W2089660436 citedByCount "77" @default.
• W2089660436 countsByYear W20896604362012 @default.
• W2089660436 countsByYear W20896604362013 @default.
• W2089660436 countsByYear W20896604362014 @default.
• W2089660436 countsByYear W20896604362015 @default.
• W2089660436 countsByYear W20896604362016 @default.
• W2089660436 countsByYear W20896604362017 @default.
• W2089660436 countsByYear W20896604362018 @default.
• W2089660436 countsByYear W20896604362019 @default.
• W2089660436 countsByYear W20896604362021 @default.
• W2089660436 countsByYear W20896604362022 @default.
• W2089660436 crossrefType "journal-article" @default.
• W2089660436 hasAuthorship W2089660436A5011425931 @default.
• W2089660436 hasAuthorship W2089660436A5044262860 @default.
• W2089660436 hasAuthorship W2089660436A5073060840 @default.
• W2089660436 hasAuthorship W2089660436A5090143035 @default.
• W2089660436 hasBestOaLocation W20896604361 @default.
• W2089660436 hasConcept C121955636 @default.
• W2089660436 hasConcept C126322002 @default.
• W2089660436 hasConcept C144133560 @default.
• W2089660436 hasConcept C160735492 @default.
• W2089660436 hasConcept C162324750 @default.
• W2089660436 hasConcept C177713679 @default.
• W2089660436 hasConcept C194828623 @default.
• W2089660436 hasConcept C2776694085 @default.
• W2089660436 hasConcept C2777063308 @default.
• W2089660436 hasConcept C2778658803 @default.
• W2089660436 hasConcept C2778850193 @default.
• W2089660436 hasConcept C2779171977 @default.
• W2089660436 hasConcept C3019354653 @default.
• W2089660436 hasConcept C50522688 @default.
• W2089660436 hasConcept C535046627 @default.
• W2089660436 hasConcept C6964187 @default.
• W2089660436 hasConcept C71924100 @default.
• W2089660436 hasConceptScore W2089660436C121955636 @default.
• W2089660436 hasConceptScore W2089660436C126322002 @default.
• W2089660436 hasConceptScore W2089660436C144133560 @default.
• W2089660436 hasConceptScore W2089660436C160735492 @default.
• W2089660436 hasConceptScore W2089660436C162324750 @default.
• W2089660436 hasConceptScore W2089660436C177713679 @default.
• W2089660436 hasConceptScore W2089660436C194828623 @default.
• W2089660436 hasConceptScore W2089660436C2776694085 @default.
• W2089660436 hasConceptScore W2089660436C2777063308 @default.
• W2089660436 hasConceptScore W2089660436C2778658803 @default.
• W2089660436 hasConceptScore W2089660436C2778850193 @default.
• W2089660436 hasConceptScore W2089660436C2779171977 @default.
• W2089660436 hasConceptScore W2089660436C3019354653 @default.
• W2089660436 hasConceptScore W2089660436C50522688 @default.
• W2089660436 hasConceptScore W2089660436C535046627 @default.
• W2089660436 hasConceptScore W2089660436C6964187 @default.
• W2089660436 hasConceptScore W2089660436C71924100 @default.
• W2089660436 hasIssue "2" @default.

• next